Jacob P Laubach (Jacob Laubach)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 37

Top Topics

Multiple Myeloma

Clostridium Difficile

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer journal

British journal of haematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ajai Chari, Jonathan L Kaufman, Jacob P Laubach, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN. Blood cancer journal 14 (1) (2024)
Peter M Voorhees, Vera J Suman, Yvonne A Efebera, Noopur Raje, Sascha A Tuchman, Cesar Rodriguez, Jacob P Laubach, Misty Bova-Solem, Destin Carlisle, Saad Z Usmani, Philip L McCarthy, Paul G Richardson
Alliance A061202: Ixazomib, pomalidomide and dexamethasone for lenalidomide-refractory multiple myeloma in first relapse. Blood advances (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Ajai Chari, Jonathan L Kaufman, Jacob P Laubach, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Ajai Chari, Jonathan L Kaufman, Jacob P Laubach, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN. Blood cancer journal 14 (1) (2024)
Peter M Voorhees, Vera J Suman, Yvonne A Efebera, Noopur Raje, Sascha A Tuchman, Cesar Rodriguez, Jacob P Laubach, Misty Bova-Solem, Destin Carlisle, Saad Z Usmani, Philip L McCarthy, Paul G Richardson
Alliance A061202: Ixazomib, pomalidomide and dexamethasone for lenalidomide-refractory multiple myeloma in first relapse. Blood advances (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Ajai Chari, Jonathan L Kaufman, Jacob P Laubach, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN. Blood cancer journal 14 (1) (2024)
Ali AlJabban, Hyun-Il Paik, Jon C Aster, Nancy Berliner, Jennifer Brouillard, Jennifer R Brown, Kathleen H Burns, Jorge J Castillo, James Card, Paola Dal Cin, Daniel J DeAngelo, David M Dorfman, Benjamin L Ebert, Jacqueline S Garcia, Caron A Jacobson, Hakim Lakhani, Jacob P Laubach, Azra H Ligon, Neal I Lindeman, R Coleman Lindsley, Scott B Lovitch, Marlise R Luskin, Elizabeth A Morgan, Andrew Nowak, Athena Petrides, Geraldine S Pinkus, Olga Pozdnyakova, David P Steensma, Richard M Stone, Olga K Weinberg, Eric S Winer, Annette S Kim
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. JCO oncology practice (2023)
Peter O'Gorman, Jacob P Laubach, Michael E O'Dwyer, Janusz Krawczyk, Andrew J Yee, Oonagh Gilligan, Mary R Cahill, Jacalyn Rosenblatt, John Quinn, Philip T Murphy, Heidi DiPietro, Meegahage Ratnakanthi Perera, Gerard M Crotty, Kristen Cummings, Patrick J Hayden, Paul Browne, Alexandra Savell, Hilary M O'Leary, Denis O'Keeffe, Kelly Masone, Brian J Hennessy, Thomas Guerrero Garcia, Kathleen Scott, Khalid Saeed, Giada Bianchi, Paul Dowling, Ciara Tierney, Paul Gerard Richardson
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma. American journal of hematology 97 (5) (2022)
Johannes M Waldschmidt, Andrew J Yee, Tushara Vijaykumar, Ricardo A Pinto, Julia Frede, Praveen Anand, Giada Bianchi, Guangwu Guo, Sayalee Potdar, Charles Seifer, Monica S Nair, Antonis Kokkalis, Jake A Kloeber, Samantha Shapiro, Lillian Budano, Mason Mann, Robb Friedman, Brea Lipe, Erica Campagnaro, Elizabeth K O'Donnell, Cheng-Zhong Zhang, Jacob P Laubach, Nikhil C Munshi, Paul Gerard Richardson, Kenneth C Anderson, Noopur S Raje, Birgit Knoechel, Jens G Lohr
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma. Leukemia 36 (4) (2022)
Douglas W Sborov, Muhamed Baljevic, Brandi Reeves, Jacob P Laubach, Yvonne A Efebera, Cesar Rodriguez, Luciano José Megale Costa, Ajai Chari, Rebecca Silbermann, Sarah A Holstein, Larry D Anderson, Jonathan L Kaufman, Nina Shah, Huiling Pei, Sharmila Patel, Annelore Cortoos, J Blake Bartlett, Jessica Vermeulen, Thomas S Lin, Peter M Voorhees, Paul Gerard Richardson
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study. British journal of haematology 199 (3) (2022)
Elizabeth K O' Donnell, Yael N Shapiro, Andrew J Yee, Omar Nadeem, Jacob P Laubach, Andrew R Branagan, Kenneth C Anderson, Clifton C Mo, Nikhil C Munshi, Irene M Ghobrial, Adam S Sperling, Emerentia A Agyemang, Jill N Burke, Cynthia C Harrington, Bonnie Y Hu, Paul G Richardson, Noopur S Raje, Areej El-Jawahri
Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma. Blood advances 6 (17) (2022)
Karthik Ramasamy, Ajay K Nooka, Hang Quach, Myo Htut, Rakesh Popat, Michaela Liedtke, Sascha A Tuchman, Jacob P Laubach, Cristina Gasparetto, Asher Chanan-Khan, Mark Hertzberg, Mark deMario, Eveline Nueesch, Evelyne Chesne, Izolda Franjkovic, Katharina Lechner, Martin Kornacker, Hearn Jay Cho
A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma. Blood cancer journal 11 (9) (2021)
Paul Gerard Richardson, Shaji K Kumar, Tamás Masszi, Norbert Grzasko, Nizar J Bahlis, Markus Hansson, Luděk Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W Baker, Sharon R Jackson, Anne-Marie Stoppa, Peter Gimsing, Laurent Garderet, Cyrille Touzeau, Francis K Buadi, Jacob P Laubach, Michele Cavo, Mohamed Darif, Richard Labotka, Deborah Berg, Philippe Moreau
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Saad Z Usmani, Chatchada Karanes, William I Bensinger, Anita D Souza, Noopur Raje, Sascha A Tuchman, Douglas Sborov, Jacob P Laubach, Giada Bianchi, Dheepak Kanagavel, Rao Saleem, Franck Dubin, Frank Campana, Paul Gerard Richardson
Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma. Leukemia 35 (12) (2021)
Johannes Moritz Waldschmidt, Jake A Kloeber, Praveen Anand, Julia Frede, Antonis Kokkalis, Valeriya Dimitrova, Sayalee Potdar, Monica S Nair, Tushara Vijaykumar, Nam Gyu Im, Amy Guillaumet-Adkins, Nitish Chopra, Hannah Stuart, Lillian Budano, Noori Sotudeh, Guangwu Guo, Clemens Grassberger, Andrew J Yee, Jacob P Laubach, Paul Gerard Richardson, Kenneth C Anderson, Noopur S Raje, Birgit Knoechel, Jens G Lohr
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Jacob P Laubach, Sascha A Tuchman, Jacalyn M Rosenblatt, Constantine S Mitsiades, Kathleen Colson, Kelly Masone, Diane Warren, Robert A Redd, Dena Grayson, Paul Gerard Richardson
Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma. Blood cancer journal 11 (2) (2021)
Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, Joan Bladé, Agne Paner, Maria-Victoria Mateos-Manteca, Michele Cavo, Christopher Maisel, Adrían Alegre, Albert Oriol, Anastasios Raptis, Paula Rodriguez Otero, Amitabha Mazumder, Jacob P Laubach, Omar Nadeem, Anna Sandberg, Marie Orre, Anna Torrång, Nicolaas A Bakker, Paul Gerard Richardson
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. British journal of haematology (2021)
Steven P Treon, Kirsten Meid, Joshua Gustine, Guang Yang, Lian Xu, Xia Liu, Christopher J Patterson, Zachary R Hunter, Andrew R Branagan, Jacob P Laubach, Irene M Ghobrial, Maria Lia Palomba, Ranjana H Advani, Jorge J Castillo
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2020)
Paul Gerard Richardson, Arnon Nagler, Dina Ben-Yehuda, Ashraf Badros, Parameswaran N Hari, Roman Hájek, Ivan Spicka, Hakan Kaya, Richard LeBlanc, Sung-Soo Yoon, Kihyun Kim, Joaquin Martinez-Lopez, Moshe Mittelman, Ofer Shpilberg, Paul Blake, Teru Hideshima, Kathleen Colson, Jacob P Laubach, Irene M Ghobrial, Merav Leiba, Moshe E E Gatt, Peter Sportelli, Michael Chen, Kenneth C Anderson
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib. EJHaem 1 (1) (2020)
Paul Gerard Richardson, Albert Oriol, Alessandra Larocca, Joan Bladé, Michele Cavo, Paula Rodriguez-Otero, Xavier Leleu, Omar Nadeem, John W Hiemenz, Hani Hassoun, Cyrille Touzeau, Adrián Alegre, Agne Paner, Christopher Maisel, Amitabha Mazumder, Anastasios Raptis, Jan S Moreb, Kenneth C Anderson, Jacob P Laubach, Sara Thuresson, Marcus Thuresson, Catriona Byrne, Johan Harmenberg, Nicolaas A Bakker, María-Victoria Mateos, null null
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)
Torben Plesner, Hendrik-Tobias Arkenau, Francesca Gay, Monique C Minnema, Mario Boccadoro, Phillipe Moreau, Jamie Cavenagh, Aurore Perrot, Jacob P Laubach, Jakub Krejcik, Tahamtan Ahmadi, Carla de Boer, Diana Chen, Christopher Chiu, Jordan M Schecter, Paul Gerard Richardson
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study. British journal of haematology 186 (3) (2019)
Paul Gerard Richardson, William I Bensinger, Carol Ann Huff, Caitlin L Costello, Nikoletta Lendvai, Jesus G Berdeja, Larry D Anderson, David S Siegel, Daniel Lebovic, Sundar Jagannath, Jacob P Laubach, Keith E Stockerl-Goldstein, Long Kwei, Fong Clow, Laurence Elias, Zeena Salman, Thorsten Graef, Elizabeth Bilotti, Ravi Vij
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results. British journal of haematology 180 (6) (2018)
Sundar Jagannath, Jacob P Laubach, Ellice Wong, Keith Stockerl-Goldstein, Cara Rosenbaum, Madhav Dhodapkar, Ying-Ming Jou, Mark Lynch, Michael Robbins, Suresh Shelat, Kenneth C Anderson, Paul Gerard Richardson
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study. British journal of haematology 182 (4) (2018)
Cindy Varga, Jacob P Laubach, Kenneth C Anderson, Paul Gerard Richardson
Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma. British journal of haematology 181 (4) (2018)
Michael G Fradley, John D Groarke, Jacob P Laubach, Melissa Alsina, Daniel J Lenihan, Robert Frank Cornell, Michelle Maglio, Kenneth H Shain, Paul Gerard Richardson, Javid Moslehi
Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. British journal of haematology 180 (2) (2017)
Shaji K Kumar, Jacob P Laubach, Thomas J Giove, Maureen Quick, Rachel Neuwirth, Godwin Yung, S Vincent Rajkumar, Paul G Richardson
Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma. British journal of haematology 178 (5) (2017)
Jacob P Laubach, Javid J Moslehi, Sanjeev A Francis, Jesús F San Miguel, Pieter Sonneveld, Robert Z Orlowski, Phillipe Moreau, Laura Rosiñol, Edward A Faber, Peter Voorhees, Maria-Victoria Mateos, Loreta Marquez, Huaibao Feng, Avinash Desai, Helgi van de Velde, Jennifer Elliott, Hongliang Shi, Edward Dow, Nishith Jobanputra, Dixie-Lee Esseltine, Liviu Niculescu, Kenneth C Anderson, Sagar Lonial, Paul G Richardson
A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma. British journal of haematology 178 (4) (2017)
Andrew Spencer, Simon Harrison, Jeffrey Zonder, Ashraf Badros, Jacob P Laubach, Krystal Bergin, Amit Khot, Todd Zimmerman, Dharminder Chauhan, Nancy Levin, Ann MacLaren, Steven D Reich, Mohit Trikha, Paul Gerard Richardson
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results. British journal of haematology 180 (1) (2017)